Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


ReNeuron Stroke Clinical Trial Cleared to Dose Remaining Patients - First Patient in Final Dose Cohort Treated 

 

January 29, 2013 - (ReNeuron) - "In this open label, dose-ranging Phase I safety study, taking place in Scotland, ReNeuron's ReN001 stem cell therapy is being administered in ascending doses to a total of 12 stroke patients who have been left disabled by an ischaemic stroke, the most common form of the condition." Read Full Press Release

 

Posted on 4-Feb-13 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: